$MIRM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Mirum Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Mirum Pharmaceuticals, Inc.. Get notifications about new insider transactions in Mirum Pharmaceuticals, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 12 2021 | MIRM | Mirum Pharmaceutic ... | Vig Pamela | Chief Scientific Of ... | Grant | A | 14.62 | 699 | 10,219 | 2,906 | 2.2 K to 2.9 K (+31.67 %) |
May 12 2021 | MIRM | Mirum Pharmaceutic ... | Tucker Edwin Jonathan | Chief Medical Offic ... | Grant | A | 14.62 | 1,483 | 21,681 | 39,007 | 37.5 K to 39 K (+3.95 %) |
May 12 2021 | MIRM | Mirum Pharmaceutic ... | Radovich Peter | Chief Operating Off ... | Grant | A | 14.62 | 1,006 | 14,708 | 4,512 | 3.5 K to 4.5 K (+28.69 %) |
May 12 2021 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Grant | A | 14.62 | 1,453 | 21,243 | 2,824 | 1.4 K to 2.8 K (+105.98 %) |
May 12 2021 | MIRM | Mirum Pharmaceutic ... | Longpre Lara | Chief Development O ... | Grant | A | 14.62 | 1,259 | 18,407 | 77,081 | 75.8 K to 77.1 K (+1.66 %) |
May 12 2021 | MIRM | Mirum Pharmaceutic ... | Clements Ian | Chief Financial Off ... | Grant | A | 14.62 | 981 | 14,342 | 8,852 | 7.9 K to 8.9 K (+12.46 %) |
Mar 08 2021 | MIRM | Mirum Pharmaceutic ... | Tucker Edwin Jonathan | Chief Medical Offic ... | Option Exercise | M | 7.70 | 1,082 | 8,331 | 69,751 | |
Mar 08 2021 | MIRM | Mirum Pharmaceutic ... | Tucker Edwin Jonathan | Chief Medical Offic ... | Buy | M | 7.70 | 1,082 | 8,331 | 37,524 | 36.4 K to 37.5 K (+2.97 %) |
Jan 11 2021 | MIRM | Mirum Pharmaceutic ... | Radovich Peter | Chief Operating Off ... | Option Exercise | A | 19.19 | 65,000 | 1,247,350 | 65,000 | |
Jan 11 2021 | MIRM | Mirum Pharmaceutic ... | Vig Pamela | Chief Scientific Of ... | Option Exercise | A | 19.19 | 65,000 | 1,247,350 | 65,000 | |
Jan 11 2021 | MIRM | Mirum Pharmaceutic ... | Clements Ian | Chief Financial Off ... | Option Exercise | A | 19.19 | 75,000 | 1,439,250 | 75,000 | |
Jan 11 2021 | MIRM | Mirum Pharmaceutic ... | Longpre Lara | Chief Development O ... | Option Exercise | A | 19.19 | 65,000 | 1,247,350 | 65,000 | |
Jan 11 2021 | MIRM | Mirum Pharmaceutic ... | Tucker Edwin Jonathan | Chief Medical Offic ... | Option Exercise | A | 19.19 | 65,000 | 1,247,350 | 65,000 | |
Jan 11 2021 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Option Exercise | A | 19.19 | 175,000 | 3,358,250 | 175,000 | |
Dec 29 2020 | MIRM | Mirum Pharmaceutic ... | Tucker Edwin Jonathan | Chief Medical Offic ... | Option Exercise | M | 7.70 | 4,167 | 32,086 | 70,833 | |
Dec 29 2020 | MIRM | Mirum Pharmaceutic ... | Tucker Edwin Jonathan | Chief Medical Offic ... | Buy | M | 7.70 | 4,167 | 32,086 | 36,442 | 32.3 K to 36.4 K (+12.91 %) |
Dec 28 2020 | MIRM | Mirum Pharmaceutic ... | Clements Ian | Chief Financial Off ... | Buy | P | 18.65 | 1,562 | 29,131 | 7,841 | 6.3 K to 7.8 K (+24.88 %) |
Dec 28 2020 | MIRM | Mirum Pharmaceutic ... | Clements Ian | Chief Financial Off ... | Buy | P | 18.55 | 908 | 16,843 | 6,279 | 5.4 K to 6.3 K (+16.91 %) |
Dec 28 2020 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Buy | P | 18.60 | 2,000 | 37,200 | 201,570 | 199.6 K to 201.6 K (+1.00 %) |
Dec 28 2020 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Buy | P | 18.76 | 3,000 | 56,280 | 199,570 | 196.6 K to 199.6 K (+1.53 %) |
Nov 12 2020 | MIRM | Mirum Pharmaceutic ... | Vig Pamela | Chief Scientific Of ... | Grant | A | 15.27 | 595 | 9,083 | 2,207 | 1.6 K to 2.2 K (+36.91 %) |
Nov 12 2020 | MIRM | Mirum Pharmaceutic ... | Radovich Peter | Chief Operating Off ... | Grant | A | 15.27 | 861 | 13,144 | 3,506 | 2.6 K to 3.5 K (+32.55 %) |
Nov 12 2020 | MIRM | Mirum Pharmaceutic ... | Longpre Lara | Chief Development O ... | Grant | A | 15.27 | 822 | 12,549 | 75,822 | 75 K to 75.8 K (+1.10 %) |
Nov 12 2020 | MIRM | Mirum Pharmaceutic ... | Tucker Edwin Jonathan | Chief Medical Offic ... | Grant | A | 15.27 | 1,275 | 19,464 | 32,275 | 31 K to 32.3 K (+4.11 %) |
Nov 12 2020 | MIRM | Mirum Pharmaceutic ... | Clements Ian | Chief Financial Off ... | Grant | A | 15.27 | 1,371 | 20,930 | 5,371 | 4 K to 5.4 K (+34.28 %) |
Nov 12 2020 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Grant | A | 15.27 | 1,371 | 20,930 | 1,371 | 0 to 1.4 K |
Nov 03 2020 | MIRM | Mirum Pharmaceutic ... | Tucker Edwin Jonathan | Chief Medical Offic ... | Option Exercise | M | 7.70 | 25,000 | 192,500 | 75,000 | |
Nov 03 2020 | MIRM | Mirum Pharmaceutic ... | Tucker Edwin Jonathan | Chief Medical Offic ... | Buy | M | 7.70 | 25,000 | 192,500 | 31,000 | 6 K to 31 K (+416.67 %) |
Jun 15 2020 | MIRM | Mirum Pharmaceutic ... | Mathers Edward T | Director | Option Exercise | A | 16.71 | 17,000 | 284,070 | 17,000 | |
Jun 15 2020 | MIRM | Mirum Pharmaceutic ... | Fischer Laurent | Director | Option Exercise | A | 16.71 | 17,000 | 284,070 | 17,000 | |
Jun 15 2020 | MIRM | Mirum Pharmaceutic ... | GREY MICHAEL G | Director | Option Exercise | A | 16.71 | 17,000 | 284,070 | 17,000 | |
Apr 30 2020 | MIRM | Mirum Pharmaceutic ... | Radovich Peter | Chief Operating Off ... | Option Exercise | A | 16.26 | 185,000 | 3,008,100 | 185,000 | |
Mar 23 2020 | MIRM | Mirum Pharmaceutic ... | Tucker Edwin Jonathan | Chief Medical Offic ... | Buy | P | 11.90 | 2,500 | 29,740 | 6,000 | 3.5 K to 6 K (+71.43 %) |
Mar 23 2020 | MIRM | Mirum Pharmaceutic ... | Tucker Edwin Jonathan | Chief Medical Offic ... | Buy | P | 9.91 | 2,000 | 19,818 | 3,500 | 1.5 K to 3.5 K (+133.33 %) |
Jan 14 2020 | MIRM | Mirum Pharmaceutic ... | Vig Pamela | Chief Scientific Of ... | Option Exercise | A | 19.24 | 52,000 | 1,000,480 | 52,000 | |
Jan 14 2020 | MIRM | Mirum Pharmaceutic ... | Tucker Edwin Jonathan | Chief Medical Offic ... | Option Exercise | A | 19.24 | 20,000 | 384,800 | 20,000 | |
Jan 14 2020 | MIRM | Mirum Pharmaceutic ... | Longpre Lara | Chief Development O ... | Option Exercise | A | 19.24 | 52,000 | 1,000,480 | 52,000 | |
Jan 14 2020 | MIRM | Mirum Pharmaceutic ... | Clements Ian | Chief Financial Off ... | Option Exercise | A | 19.24 | 65,000 | 1,250,600 | 65,000 | |
Jan 14 2020 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Option Exercise | A | 19.24 | 170,000 | 3,270,800 | 170,000 | |
Jan 02 2020 | MIRM | Mirum Pharmaceutic ... | GREY MICHAEL G | Director | Option Exercise | A | 24.52 | 100,000 | 2,452,000 | 100,000 | |
Oct 28 2019 | MIRM | Mirum Pharmaceutic ... | Tucker Edwin Jonathan | Chief Medical Offic ... | Option Exercise | A | 7.70 | 100,000 | 770,000 | 100,000 | |
Sep 18 2019 | MIRM | Mirum Pharmaceutic ... | Fischer Laurent | Director | Buy | P | 9.37 | 1,648 | 15,435 | 6,750 | 5.1 K to 6.8 K (+32.30 %) |
Sep 18 2019 | MIRM | Mirum Pharmaceutic ... | Fischer Laurent | Director | Buy | P | 9.47 | 452 | 4,280 | 5,102 | 4.7 K to 5.1 K (+9.72 %) |
Sep 12 2019 | MIRM | Mirum Pharmaceutic ... | Brege Laura | Director | Buy | P | 11.22 | 10,000 | 112,200 | 10,000 | 0 to 10 K |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Clements Ian | SVP Finance & Commu ... | Buy | P | 11.87 | 2,199 | 26,102 | 4,000 | 1.8 K to 4 K (+122.10 %) |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Clements Ian | SVP Finance & Commu ... | Buy | P | 11.87 | 2,199 | 26,102 | 4,000 | 1.8 K to 4 K (+122.10 %) |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Clements Ian | SVP Finance & Commu ... | Buy | P | 11.07 | 1,801 | 19,937 | 1,801 | 0 to 1.8 K |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Clements Ian | SVP Finance & Commu ... | Buy | P | 11.07 | 1,801 | 19,937 | 1,801 | 0 to 1.8 K |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Vig Pamela | Chief Scientific Of ... | Buy | P | 11.88 | 12 | 143 | 1,612 | 1.6 K to 1.6 K (+0.75 %) |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Vig Pamela | Chief Scientific Of ... | Buy | P | 11.88 | 12 | 143 | 1,612 | 1.6 K to 1.6 K (+0.75 %) |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Vig Pamela | Chief Scientific Of ... | Buy | P | 10.96 | 1,600 | 17,539 | 1,600 | 0 to 1.6 K |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Vig Pamela | Chief Scientific Of ... | Buy | P | 10.96 | 1,600 | 17,539 | 1,600 | 0 to 1.6 K |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Buy | P | 11.35 | 2,320 | 26,332 | 196,570 | 194.3 K to 196.6 K (+1.19 %) |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Buy | P | 11.35 | 2,320 | 26,332 | 196,570 | 194.3 K to 196.6 K (+1.19 %) |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Buy | P | 10.90 | 2,000 | 21,800 | 194,250 | 192.3 K to 194.3 K (+1.04 %) |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Buy | P | 10.90 | 2,000 | 21,800 | 194,250 | 192.3 K to 194.3 K (+1.04 %) |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Buy | P | 10.91 | 4,750 | 51,806 | 192,250 | 187.5 K to 192.3 K (+2.53 %) |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Peetz Christopher | President and CEO | Buy | P | 10.91 | 4,750 | 51,806 | 192,250 | 187.5 K to 192.3 K (+2.53 %) |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Fischer Laurent | Director | Buy | P | 10.29 | 960 | 9,881 | 4,650 | 3.7 K to 4.7 K (+26.02 %) |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Fischer Laurent | Director | Buy | P | 10.29 | 960 | 9,881 | 4,650 | 3.7 K to 4.7 K (+26.02 %) |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Fischer Laurent | Director | Buy | P | 11.30 | 300 | 3,390 | 3,690 | 3.4 K to 3.7 K (+8.85 %) |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Fischer Laurent | Director | Buy | P | 11.30 | 300 | 3,390 | 3,690 | 3.4 K to 3.7 K (+8.85 %) |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Fischer Laurent | Director | Buy | P | 10.54 | 1,670 | 17,602 | 3,390 | 1.7 K to 3.4 K (+97.09 %) |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Fischer Laurent | Director | Buy | P | 10.54 | 1,670 | 17,602 | 3,390 | 1.7 K to 3.4 K (+97.09 %) |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Fischer Laurent | Director | Buy | P | 10.71 | 1,720 | 18,429 | 1,720 | 0 to 1.7 K |
Sep 10 2019 | MIRM | Mirum Pharmaceutic ... | Fischer Laurent | Director | Buy | P | 10.71 | 1,720 | 18,429 | 1,720 | 0 to 1.7 K |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Walker Paul Edward | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Walker Paul Edward | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Walker Paul Edward | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Sonsini Peter W. | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Sonsini Peter W. | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Sonsini Peter W. | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | SANDELL SCOTT D | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | MOTT DAVID M | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | MAKOWER JOSHUA | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | MAKOWER JOSHUA | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | MAKOWER JOSHUA | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Makhzoumi Mohamad | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Makhzoumi Mohamad | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Makhzoumi Mohamad | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Florence Anthony A. Jr. | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Florence Anthony A. Jr. | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Florence Anthony A. Jr. | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Florence Anthony A. Jr. | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Chang Carmen | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Chang Carmen | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Chang Carmen | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Chang Carmen | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Chang Carmen | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Chang Carmen | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Behbahani Ali | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Behbahani Ali | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Behbahani Ali | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Behbahani Ali | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Behbahani Ali | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Behbahani Ali | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | BASKETT FOREST | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | BASKETT FOREST | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | BASKETT FOREST | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | BASKETT FOREST | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | BASKETT FOREST | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | BASKETT FOREST | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | BARRIS PETER J | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | BARRIS PETER J | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | BARRIS PETER J | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | BARRIS PETER J | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | BARRIS PETER J | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | BARRIS PETER J | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | New Enterprise Associates 16, ... | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | New Enterprise Associates 16, ... | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | New Enterprise Associates 16, ... | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | New Enterprise Associates 16, ... | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | New Enterprise Associates 16, ... | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | New Enterprise Associates 16, ... | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Frazier Life Sciences IX, L.P. | 10% Owner | Option Exercise | C | 0.00 | 24,935,300 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Frazier Life Sciences IX, L.P. | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 3,566,912 | 3.1 M to 3.6 M (+14.44 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Frazier Life Sciences IX, L.P. | 10% Owner | Buy | C | 0.00 | 3,116,912 | 0 | 3,116,912 | 0 to 3.1 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | O'Donnell Niall | Director | Option Exercise | C | 0.00 | 11,968,944 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | O'Donnell Niall | Director | Buy | P | 15.00 | 300,000 | 4,500,000 | 1,921,118 | 1.6 M to 1.9 M (+18.51 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | O'Donnell Niall | Director | Buy | C | 0.00 | 1,496,118 | 0 | 1,621,118 | 125 K to 1.6 M (+1,196.89 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Heron Patrick J | Director | Option Exercise | C | 0.00 | 24,935,300 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Heron Patrick J | Director | Buy | P | 15.00 | 450,000 | 6,750,000 | 3,566,912 | 3.1 M to 3.6 M (+14.44 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Heron Patrick J | Director | Buy | C | 0.00 | 3,116,912 | 0 | 3,116,912 | 0 to 3.1 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | GREY MICHAEL G | Executive Chairman | Option Exercise | C | 0.00 | 63,585 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | GREY MICHAEL G | Executive Chairman | Buy | C | 0.00 | 7,948 | 0 | 289,198 | 281.3 K to 289.2 K (+2.83 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 12,467,650 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Flynn James E | 10% Owner | Option Exercise | C | 0.00 | 12,467,650 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 15.00 | 166,000 | 2,490,000 | 166,000 | 0 to 166 K |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Flynn James E | 10% Owner | Buy | P | 15.00 | 166,000 | 2,490,000 | 1,724,456 | 1.6 M to 1.7 M (+10.65 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 1,558,456 | 0 | 1,558,456 | 0 to 1.6 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | Flynn James E | 10% Owner | Buy | C | 0.00 | 1,558,456 | 0 | 1,558,456 | 0 to 1.6 M |
Jul 23 2019 | MIRM | Mirum Pharmaceutic ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 1,870,147 | 0 | 0 | |
Jul 23 2019 | MIRM | Mirum Pharmaceutic ... | Novo Holdings A/S | 10% Owner | Buy | P | 15.00 | 575,000 | 8,625,000 | 2,445,147 | 1.9 M to 2.4 M (+30.75 %) |
Jul 23 2019 | MIRM | Mirum Pharmaceutic ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 1,870,147 | 0 | 1,870,147 | 0 to 1.9 M |
Jul 18 2019 | MIRM | Mirum Pharmaceutic ... | Brege Laura | Director | Option Exercise | A | 15.00 | 17,000 | 255,000 | 17,000 |
Page: 1